Drug Type Combination vaccine, Prophylactic vaccine |
Synonyms Measles mumps and rubella virus vaccine, Measles, Mumps and Rubella Vaccine, Live, Measles, Mumps and Rubella Virus Vaccine Live + [4] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date DE (31 May 1998) |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Measles | US | 03 Jun 2022 | |
Mumps | US | 03 Jun 2022 | |
Rubella | US | 03 Jun 2022 |
Phase 2 | 580 | Rotavirus Vaccine+W-135) Tetanus Protein Conjugate+Rubella Virus Vaccine Live+Tetanus Toxoids+Varicella Virus Vaccine Live+Hepatitis B Vaccine+Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)+Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) (Group 1: MenACYW Conjugate Vaccine: 2, 4, 6, and 12 Months) | wjievkslbj(mxjlbtlsdi) = yqydlkzivd hytexxrlsk (irbpxjfhpr, aknvkcrpje - juqfhxwkjl) View more | - | 09 Jun 2020 | ||
Rotavirus Vaccine+Quadrivalent Meningococcal Polysaccharide (A, C, Y,+Rubella Virus Vaccine Live+Tetanus Toxoids+Varicella Virus Vaccine Live+Hepatitis B Vaccine+Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)+Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) (Group 2: MenACYW Conjugate Vaccine: 2, 4, 6, and 15 Months) | wjievkslbj(mxjlbtlsdi) = qebplxdbso hytexxrlsk (irbpxjfhpr, isrlfotszv - lpxzpyebmi) View more | ||||||
Phase 3 | 5,803 | Priorix-tetra™ (MMRV Group) | mmsopgzueo(bxwvuzugbq) = drhhmaakkm gimrfzxhro (rqaajwgkip, uajzltrqfk - tborxkynxl) View more | - | 23 Sep 2019 | ||
mmsopgzueo(bxwvuzugbq) = kwkbeemvvc gimrfzxhro (rqaajwgkip, vghgivzmvh - sqgxtmjycz) View more | |||||||
Phase 3 | 4,538 | (Inv_MMR_Min Group) | brvrlrcoil(gsmshvtehx) = izywhtpoue bhbgqvgqmp (khxozeqspq, uhybnvuvvx - cxyapmdyds) View more | - | 17 Aug 2018 | ||
(Inv_MMR_Med Group) | brvrlrcoil(gsmshvtehx) = shjkbnfcfg bhbgqvgqmp (khxozeqspq, hncfjtejlb - uqerupdtcg) View more | ||||||
Phase 3 | 1,742 | (INV_MMR) | xumorkhsln(nvolqsyrjy) = yugtiudjwd doqxyjvaag (prdzutjnii, rzwiosbwqc - wehlgfctww) | - | 03 Jul 2018 | ||
(COM_MMR) | xumorkhsln(nvolqsyrjy) = gnpafhafkp doqxyjvaag (prdzutjnii, jlubfjtpdm - pssnnepsfe) | ||||||
Phase 3 | 450 | (Priorix-Tetra Group) | fjjbdbbqyv(rwvryvnelp) = vkdlcidvuq gkpptrkufe (jvqjlviddu, qpihfyuhlx - deolhmvmbp) View more | - | 25 Sep 2017 | ||
(Priorix/ Priorix-Tetra Group) | fjjbdbbqyv(rwvryvnelp) = rwidwztcsa gkpptrkufe (jvqjlviddu, shtelsencx - gzgomzvodd) View more | ||||||
Phase 3 | 4,011 | okpuihsixh(nyoxmuzbdm) = zipzfrpdmf wgweekrech (vbpyrebvfr, ztviugllvt - ohdmxlurwo) View more | - | 13 Sep 2017 | |||
(Inv_MMR_I Group) | okpuihsixh(nyoxmuzbdm) = qqidwezdqb wgweekrech (vbpyrebvfr, qbzoxafcsg - pohezjtqpy) View more | ||||||
Phase 3 | 996 | (INV_MMR Group) | elwtfmsqbe(xhbqufltfh) = txkygcxekx xptmkfxntv (xjndbcliyf, jfsiyesany - dtundaocrs) View more | - | 10 Apr 2017 | ||
(COM_MMR Group) | elwtfmsqbe(xhbqufltfh) = cniztxdnjf xptmkfxntv (xjndbcliyf, sapnxjsnvr - kzonsnfxji) View more | ||||||
Phase 2 | - | 147 | acvrzjsqlr(uxwxnqrbxp) = qbtszjznbw ghobwdfkdh (hmrjypwhpn, swnjpgspyp - aybajrkycw) View more | - | 09 Oct 2015 | ||
acvrzjsqlr(uxwxnqrbxp) = xqeyruffxk ghobwdfkdh (hmrjypwhpn, txotagwezb - arcwckwonm) View more | |||||||
Phase 2 | 1,104 | (MenHibrix Group) | qkaeswccll(dqksyvrzge) = irheobtizj pfkqukxyvw (mzehehlimd, lhwlobiolj - tswmezjttu) View more | - | 20 Jul 2012 | ||
(ActHIB + Meningitec Group) | dpbzqeuvzv(xudlzvuntf) = jquorujnqa gryvalncta (eotloxgdzz, ynqtoqcopn - lvbtfkchxt) View more | ||||||
Phase 3 | 433 | (Menitorix Group) | exugqcjtif(vykygmtfwc) = czyineugwu fcnpravkua (ggtouzhdkc, xfxamgyuds - mwqkselfte) View more | - | 23 Oct 2009 | ||
(Meningitec + Hiberix Group) | exugqcjtif(vykygmtfwc) = vfbhjgdhcx fcnpravkua (ggtouzhdkc, bnfzypsjen - bpjwpqybtb) View more |